Current Approaches on Gastroretentive Drug Delivery systems

  • Aniket Uttam Pund Research scholar, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Maharashtra, India
  • Raosaheb Sopanrao Shendge Professor, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Maharashtra, India
  • Ajinkya Kailas Pote Research scholar, Department of Pharmaceutics (PG), Sanjivani College of Pharmaceutical Education and Research, Kopargaon,Maharashtra, India

Abstract

Over recent years, there have been many efforts to develop the absorption rate of medications and the therapeutic efficacy of oral dosage types. GRDDS for strengthen the pharmacological effects of drugs with a small uptake site, are unbalanced at pH greater than 7, are dissolved under acidic region, and are effective local region in the stomach. The gastro retentive systems that have the different evaluation parameter that according to the dosage forms. There are many criteria for the choosing of the drug used in the gastro-retardant systems as the drug should be sparingly stable, it should be compatible with the gastric region, and narrow absorption. In this review, we have summarized the information related to the various approaches for enhancing and prolonging of the dosage forms in the stomach for their extended-release of action. Also talking about the many natural and synthetic polymers is used in the formulation with their different grade and their ratio that affects on the release action. The many scientist and inventors have increased their interest in developing the novel dosage forms and they staying in the stomach for showing the prolonged period action. We have also discussed the novel technology are involved in the gastric retention many companies has been developed the polymer grades for using it in the formulation for showing the retention action.


Keywords: Introduction, Approaches, Novel technologies, Polymer used in floating systems.

Downloads

Download data is not yet available.

References

1.Patil H, Tiwari RV, Repka MA. advancements in bioadhesive floating drug delivery systems: A mini-review. J Drug Deliv Sci Technology 2016; 31:65-71.
2.GhoshD.Ghosh R. Floating drug delivery systems:review. Int J Pharm Med 2013;35:10-15.
4.Streubel A, Siepmann J, Bodmeier R. Drug delivery to gastroretentive technologies. Currt opini in pharmacology. 2006; 6(5):501-8.
5.Singh B et al. QbD-enabled development of novel stimuli-responsive gastroretentive systems of acyclovir for improved patient compliance and biopharmaceutical performance. AAPS PharmSciTech. 2016; 17(2):454-65.
6.Malpure PS,Chavan BR. GASTRORETENTIVE DRUG DELIVERY SYSTEMS. wjpps. 2019; 8(3):506-28.
7.Tomar A, Upadhyay A, Gupta S, Kumar S. An Overview on Gastroretentive Drug Delivery System: Current Approaches and Advancements. Curnt Research in Pharma Sci 2019; 9(01)12-6.
8.Khanvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus. Adv drug delivery reviews. 2001; 48(2-3):173-93.
9.Aspden TJ et al. Chitosan as a nasal delivery system. Journal of pharmaceutical sciences 1997; 86(4):509-13.
10.Garg R. Progress in controlled gastroretentive delivery systems. Tropical jrnal of pharma research 2008; 7(3):1055-66.
11.Gunda RK. Formulation Development and Evaluation of Gastro Retentive Drug Delivery Systems-A Review. Journal of Pharmacy Research 2017; 8(1):11-20.
12. More S, Gavali K, Doke O, Kasgawadek P. Gastroretentive Drug Delivery System. Journal of Drug Delivery and Therapeutics 2018; 8(4):24-35.
13.Kumar M. Approaches and Recent Patents on Gastroretentive Drug Delivery Systems. Recent patents on drug delivery & formulation 2018; 12(2):84-92.
14.Badoni A. Review on gastro retentive drug delivery system. The pharma innovation. 2012; 1(8, Part A):32.
15.Tripathi P, Ubaidulla U, Khar RK. Floating drug delivery system. IJRDPL. 2012; 1:1-10.
16.Kim S et al. Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin. International journal of pharmaceutics. 2018; 550(1-2):160-9.
17.Meka VS, Li CE, Sheshala R. Design effervescent floating drug delivery system of theophylline using response surface methodology. Acta Pharma. 2016; 66(1):35-51.
18.Thapa P, Jeong S. Effects of formulation and process variables on gastroretentive floating tablets. Pharmaceutics. 2018;10(3):161.
19.Kriangkrai W et al. Impact of anti-tacking agents on properties of gas-entrapped membrane and effervescent floating tablets. AAPS PharmSciTech. 2014; 15(6):1357-69.
20. Parajapati S, Maurya S, Das M, Tilak VK, Verma KK, Dhakar RC. Potential Application of Dendrimers in Drug Delivery: A Concise Review and Update. Journal of Drug Delivery and Therapeutics, 2016; 6(2):71-88.
21.Tripathi J, Thapa P. Review on gastroretentive drug delivery systems. Pharmaceutics. 2019; 11(4):193.
22.Shah S, Patel J, Patel N. floating drug delivery system: A review. Int J Pharm Tech Res. 2009; 1(3):623-33.
23.Bardonnet P, Faivre V. Gastroretentive dosage forms: Overview Helicobacter pylori. Journal of controlled release. 2006; 111(1-2):1-18.
24.Deshpande AA, Shah NH. Development of a novel controlled-release system for gastric retention. Pharmaceutical research. 1997; 14(6):815-9.
25.Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets. AAPS PharmSciTech. 2006; 7(1):E19-E28.
26.Nayak AK, Malakar J. Gastroretentive drug delivery technologies. Journal of Pharmaceutical Education & Research. 2010; 1(2).
27.Nayak AK, Das B, Maji R. Gastroretentive systems of ofloxacin. Saudi Pharmaceutical Journal. 2013; 21(1):113-7.
28.Chudiwal V, Shahi S, Chudiwal S, Ahale D. Innovative Technologies for Gastro-Retentive. Asin Jrnl of Pharma Edu and Research. 2017; 6(4):22-8.
29.Kas HS. Chitosan: In microparticulate systems. Journal of microencapsulation. 1997; 14(6):689-711.
30.Kaushik AY, Tiwari AK. Role of excipients and polymeric advancements in floating drug delivery systems. Int jrnl of pharma invest. 2015; 5(1):1.
31.Bandana S, Jovita K, Manisha P. Formulation floating microspheres of famotidine. Metabolism. 2010; 3:4.
32.Kumar MNR. A review of chitin and chitosan applications. 2000; 46(1):1-27.
33.Ali A, Shahid MA, Hossain MD, Islam MN. Antibacterial bi-layered polyvinyl alcohol (PVA)-chitosan blend nanofibrous mat loaded with Azadirachta indica (neem) extract. International journal of biological macromolecules. 2019; 138:13-20.
34.Sungthongjeen S, Sriamornsak P. Design of floating HPMC matrix tablets. Advanced Materials Research; 2011: Trans Tech Publ.
35.Zema L, Maroni A. Different HPMC viscosity grades as coating agents for an oral time and/or site‐controlled delivery system. Journal of pharmaceutical sciences. 2007; 96(6):1527-36.
36.Karthikeyan D, Karthikeyan M. Effect of different viscosity grades of HPMC on drug release profile. J Pharm Res. 2008; 1(1):23-8.
37.Roy H, Brahma CK. Formulation and design of sustained release matrix tablets of metformin hydrochloride. International Journal of Applied and Basic Medical Research. 2013; 3(1):55.
38.Thakral S, Thakral NK, Majumdar DK. Eudragit®: a technology evaluation. Expert opin on drug delivery. 2013; 10(1):131-49.
39.Nikam VK, Kotade K. Eudragit a versatile polymer: a review. Pharmacologyonline. 2011; 1:152-64.
40.Pande AV, Vaidya PD. In vitro and in vivo evaluation of floating microspheres of cefpodoxime proxetil. Int J Pharm Biomed Res. 2010;1(4):122-8.
41.Chandran S, Asghar LF. Design and evaluation of ethyl cellulose based matrix tablets of ibuprofen . Indian journal of pharmaceutical sciences. 2008; 70(5):596.
42.Krishnaiah Y, Karthikeyan R. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Int jrnal of pharma. 2002; 241(2):353-66.
43.Sharma G, Sharma S, Kumar A. Guar gum review. Carbohydrate polymers. 2018; 199:534-45.
44.Kumar SA, Vivek D, Vandana A. polymers used in floating drug delivery system. Journal of Pharma and Sci Innovation. 2012; 1(3):11-5.
45.Kanwar N, Kumar R. Preparation of floating tablets of pregabalin. Drug development and industrial pharmacy. 2016; 42(4):654-60.
46.Prakash U, Singh L, Sharma V. Role of xanthan gum in gastroretentive drug delivery system: An overview. Int Res J Pharm. 2013; 4(4):35.
47.Panda S, Sailada NS, Devi B, Pattnaik S, Maharana L. Design of Floating Drug Delivery Systems: An Update on Polymeric Advancements with Special Reference from Natural Origin.
48.Gandhi A, Verma S, Imam SS, Vyas M. A REVIEW ON TECHNIQUES FOR GRAFTING OF NATURAL POLYMERS AND THEIR APPLICATIONS. Plant Archives. 2019; 19(2):972-8.
49.Bomma R, Naidu RS.gastroretentive norfloxacin floating tablets. Acta pharmaceutica. 2009; 59(2):211-21.
50.Sriamornsak P. pectin in oral drug delivery. Expert opinion on drug delivery. 2011; 8(8):1009-23.
51.Thakur BR, Singh RK. pectin—a review. Critical Reviews in Food Science & Nutrition. 1997; 37(1):47-73.
52.Sundar Raj A, Rubila S. A review on pectin. Scientific reports. 2012; 1:550-1.
Statistics
2 Views | 0 Downloads
How to Cite
Pund, A., Shendge, R., & Pote, A. (2020). Current Approaches on Gastroretentive Drug Delivery systems. Journal of Drug Delivery and Therapeutics, 10(1), 139-146. https://doi.org/10.22270/jddt.v10i1.3803